ORGANOGENESIS HOLDINGS INC. Property, Plant and Equipment
ORGANOGENESIS HOLDINGS INC. (ORGO) had Property, Plant and Equipment of $101.53 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Net $101.53M.
- 2026-03-31: Property, Plant and Equipment, Net $104.08M.
- 2025-12-31: Property, Plant and Equipment, Net $103.71M.
- 2025-09-30: Property, Plant and Equipment, Net $78.06M.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $101.53M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $104.08M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $103.71M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $78.06M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $75.61M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $75.52M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $89.13M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $89.87M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $89.95M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $114.25M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $116.23M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $117.50M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $111.83M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $106.64M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $102.46M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $97.01M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $93.29M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $84.27M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $79.16M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $74.77M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $69.74M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $62.43M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $55.79M 10-K · filed 2022-03-01 | $60.07M 10-K · filed 2021-03-16 |
| 2020-09-30 | $55.94M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $53.03M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $50.07M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $47.18M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $44.25M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $40.75M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $39.45M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $39.62M 10-K · filed 2020-03-09 | |
| 2017-12-31 | $42.11M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |